Edition:
United Kingdom

Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

1.91USD
16 Nov 2018
Change (% chg)

$-0.01 (-0.52%)
Prev Close
$1.92
Open
$1.86
Day's High
$1.95
Day's Low
$1.86
Volume
29,360
Avg. Vol
23,131
52-wk High
$3.95
52-wk Low
$1.86

Chart for

About

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $27.98
Shares Outstanding(Mil.): 8.35
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -8.37 -- --
ROI: -78.33 -0.64 15.05
ROE: -191.72 0.08 16.62

Earnings vs. Estimates